The Resource Nutritional management of cancer treatment effects, Nagi B. Kumar

Nutritional management of cancer treatment effects, Nagi B. Kumar

Label
Nutritional management of cancer treatment effects
Title
Nutritional management of cancer treatment effects
Statement of responsibility
Nagi B. Kumar
Creator
Subject
Language
eng
Cataloging source
NLM
http://library.link/vocab/creatorName
Kumar, Nagi B
Illustrations
illustrations
Index
index present
LC call number
RC
Literary form
non fiction
Nature of contents
bibliography
NLM call number
  • 2012 C-996
  • QZ 266
NLM item number
K96n 2012
http://library.link/vocab/subjectName
  • Cancer
  • Neoplasms
  • Antineoplastic Agents
  • Neoplasms
  • Nutrition Therapy
  • Nutritional Status
Label
Nutritional management of cancer treatment effects, Nagi B. Kumar
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Contents
  • 2.2.
  • 4.4.3.
  • Physical Activity
  • 4.5.
  • Guidelines for Treatment
  • 4.5.1.
  • Nutrition Guidelines
  • 4.5.2.
  • Pharmacotherapy
  • 4.5.3.
  • Physical Activity
  • Prevalence of Malnutrition in Cancer Patients
  • 4.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 4.5.5.
  • Follow-up
  • 4.6.
  • Future Directions
  • References
  • 5.
  • Oral Mucositis
  • 5.1.
  • 2.3.
  • Definition
  • 5.2.
  • Prevalence
  • 5.3.
  • Etiology
  • 5.3.1.
  • Patient- and Treatment-Related Etiology of Mucositis
  • 5.3.2.
  • Biologic Development of Mucositis
  • 5.4.
  • Etiology of Malnutrition
  • Current Therapies for Mucositis
  • 5.4.1.
  • Assessment and Early Identification of Oral Mucositis
  • 5.4.2.
  • Treatment Approaches with Immunomodulators, Amino Acids, and Vitamins
  • 5.4.3.
  • Physical Approaches for the Prevention and Treatment of Oral Mucositis
  • 5.4.4.
  • Treatment Approaches of Related Symptom Clusters to Oral Mucositis
  • 5.5.
  • 2.3.1.
  • Guidelines for Assessment and Treatment of Oral Mucositis
  • 5.5.1.
  • Assessment of Mucositis
  • 5.5.2.
  • Dental Care Guidelines
  • 5.5.3.
  • Pharmacotherapy
  • 5.5.4.
  • Nutrition Guidelines
  • 5.5.5.
  • Tumor-Related Etiology
  • Physical Activity
  • 5.5.6.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 5.5.7.
  • Follow-up
  • 5.6.
  • Future Directions
  • References
  • 6.
  • Nausea and Vomiting in Cancer
  • 2.3.2.
  • 6.1.
  • Definition/Description
  • 6.2.
  • Prevalence
  • 6.3.
  • Etiology/Common Causes
  • 6.3.1.
  • Neurophysiology of Nausea and Vomiting
  • 6.3.2.
  • Cytotoxic Chemotherapy and Radiation-Induced Mechanisms
  • Treatment-Related Etiology
  • 6.3.3.
  • Tumor-Induced Nausea and Vomiting
  • 6.3.4.
  • Drugs Contributing to Nausea and Vomiting
  • 6.3.5.
  • Psychological Etiology
  • 6.4.
  • Current Treatment of Nausea and Vomiting
  • 6.4.1.
  • Pharmacological Approaches
  • 2.4.
  • 6.4.2.
  • Nonpharmacological Approaches
  • 6.5.
  • Guidelines for the Management of Nausea and Vomiting
  • 6.5.1.
  • Assessment
  • 6.5.2.
  • Pharmacologic Interventions
  • 6.5.3.
  • Nutrition Guidelines
  • Assessment of Malnutrition in Cancer Patients
  • 6.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 6.5.5.
  • Dentist
  • 6.5.6.
  • Follow-up
  • 6.6.
  • Future Directions
  • References
  • 7.
  • Machine generated contents note:
  • 2.4.1.
  • Cancer-Related Fatigue (CRF)
  • 7.1.
  • Definition
  • 7.2.
  • Prevalence
  • 7.3.
  • Etiology of Fatigue in Cancer
  • 7.3.1.
  • Physiological Factors
  • 7.3.2.
  • Nutritional Screening
  • Medications
  • 7.3.3.
  • Psychological Factors
  • 7.3.4.
  • Environmental Factors
  • 7.4.
  • Current Treatment Approaches
  • 7.4.1.
  • Assessment of Etiology of Fatigue
  • 7.4.2.
  • 2.4.2.
  • Pharmacological Approaches/Treating Comorbidities
  • 7.4.3.
  • Nonpharmacological Approaches
  • 7.5.
  • Guidelines
  • 7.5.1.
  • Comprehensive Assessment
  • 7.5.2.
  • Pharmacological Interventions
  • 7.5.3.
  • Nutritional Assessment
  • Nonpharmacological Interventions
  • 7.6.
  • Future Directions
  • References
  • 8.
  • Treatment-Induced Enteritis (Radiation- or Combination Therapy-Induced Enteropathies)
  • 8.1.
  • Definition
  • 8.2.
  • Prevalence
  • 2.5.
  • 8.3.
  • Etiology
  • 8.4.
  • Current Therapies for Treatment of Alimentary Tract Enteritis
  • 8.4.1.
  • Screening and Comprehensive Evaluation
  • 8.4.2.
  • Radiation Techniques
  • 8.4.3.
  • Surgical Management
  • Nutrition Therapy
  • 8.4.4.
  • Pharmaceutical Management
  • 8.4.5.
  • Nutritional Management
  • 8.5.
  • Guidelines for Treatment of Gastrointestinal Mucositis/Radiation Enteritis
  • 8.5.1.
  • Assessment and Medical/Surgical Management
  • 8.5.2.
  • Nutritional Assessment and Therapy
  • 2.5.1.
  • 8.5.3.
  • Pharmacotherapy
  • 8.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 8.5.5.
  • Follow-up
  • 8.6.
  • Future Directions
  • References
  • 9.
  • Estimation of Nutritional Needs
  • Neurocognitive Impairment (NI)
  • 9.1.
  • Definition
  • 9.2.
  • Prevalence
  • 9.3.
  • Etiology
  • 9.3.1.
  • Etiology of NI in All Cancers
  • 9.3.2.
  • 2.6.
  • Etiology of NI in Adult Cancers
  • 9.3.3.
  • Etiology of NI in Childhood Cancers and Adult Survivors of Childhood Cancers
  • 9.4.
  • Current Interventions for the Treatments for Chemotherapy-Induced Cognitive Impairment
  • 9.4.1.
  • Treatment of Anemia
  • 9.4.2.
  • Treatment of Fatigue
  • 9.4.3.
  • Route of Nutrition Intervention
  • Cognitive Training (CT)
  • 9.4.4.
  • Timing of Intervention
  • 9.5.
  • Guidelines
  • 9.5.1.
  • Neuropsycho-Oncology Referral
  • 9.5.2.
  • Nutrition Screening, Assessment, and Therapy
  • 9.5.3.
  • 1.
  • 2.6.1.
  • Physical Activity
  • 9.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 9.5.5.
  • Follow-up
  • 9.6.
  • Future Directions
  • References
  • 10.
  • Dysfunction of the Bowel/Constipation
  • Oral Intake
  • 10.1.
  • Definition
  • 10.2.
  • Prevalence
  • 10.3.
  • Etiology
  • 10.3.1.
  • Medications for Cancer Treatment
  • 10.3.2.
  • Tumor or Tumor-Radiation-Induced Constipation
  • 2.6.2.
  • 10.3.3.
  • Psychological Factors
  • 10.4.
  • Current Treatment for Cancer or Treatment-Induced Constipation
  • 10.4.1.
  • Assessment
  • 10.4.2.
  • Pharmacological Interventions
  • 10.4.3.
  • Nonpharmacological Approaches
  • Enteral Nutrition
  • 10.5.
  • Guidelines
  • 10.5.1.
  • Comprehensive Assessment
  • 10.5.2.
  • Pharmacotherapy
  • 10.5.3.
  • Nonpharmacological Interventions
  • 10.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 2.6.3.
  • 10.5.5.
  • Follow-up
  • 10.6.
  • Future Directions
  • References
  • 11.
  • Dysphagia
  • 11.1.
  • Definition/Description
  • 11.2.
  • Parenteral Nutrition
  • Prevalence
  • 11.3.
  • Etiology
  • 11.3.1.
  • Tumor Location-Related Effects
  • 11.3.2.
  • Chemotherapy-Related Effects
  • 11.3.3.
  • Radiation and Chemoradiation Therapy-Related Effects
  • 11.4.
  • 2.7.
  • Current Treatment Strategies for Dysphagia
  • 11.4.1.
  • Screening and Initial Assessment
  • 11.4.2.
  • Nutritional Interventions
  • 11.4.3.
  • Physical Therapy
  • 11.4.4.
  • Pharmacotherapies
  • 11.5.
  • Reassessment and Follow-up Nutritional Care
  • Guidelines
  • 11.5.1.
  • Nutrition Guidelines
  • 11.5.2.
  • Speech Pathologist/Radiologist
  • 11.5.3.
  • Nutrition Intervention
  • 11.5.4.
  • Dentist
  • 11.5.5.
  • 2.8.
  • Pharmacotherapy
  • 11.5.6.
  • Physical Activity
  • 11.5.7.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 11.5.8.
  • Follow-up
  • 11.6.
  • Future Directions
  • References
  • Patient and Family Communication/Education
  • 12.
  • Alterations in Taste and Smell
  • 12.1.
  • Definition
  • 12.2.
  • Prevalence
  • 12.3.
  • Etiology/Common Causes
  • 12.3.1.
  • Chemotherapy Induced
  • Introduction
  • 2.9.
  • 12.3.2.
  • Radiation Therapy Induced
  • 12.3.3.
  • Other Causes of Taste and Smell Alterations in Cancer
  • 12.4.
  • Current Treatment Strategies
  • 12.4.1.
  • Assessment
  • 12.4.2.
  • Pharmacological
  • Communication with Interdisciplinary Team
  • 12.4.3.
  • Nonpharmacological
  • 12.5.
  • Guidelines for Management
  • 12.5.1.
  • Education of Patient and Family About These Symptoms
  • 12.5.2.
  • Referral to Dentist
  • 12.5.3.
  • Treatment of Infections
  • 2.10.
  • 12.5.4.
  • Screening for Alterations in Taste and Smell
  • 12.5.5.
  • Current Treatment
  • 12.5.6.
  • Other Causes Must Be Examined
  • 12.5.7.
  • Nutrition Guidelines
  • 12.5.8.
  • Pharmacotherapy
  • Future Directions
  • 12.5.9.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 12.5.10.
  • Follow-up
  • 12.6.
  • Future Directions
  • References
  • References
  • 3.
  • Cancer Anorexia (CA)
  • 3.1.
  • Definition/Description
  • 3.2.
  • References
  • Prevalence
  • 3.3.
  • Etiology and Potential Mechanisms
  • 3.3.1.
  • Tumor- and Treatment-Related Etiology of Anorexia
  • 3.3.2.
  • Perturbations of the Physiological Regulation of Eating Behavior as Etiology of Anorexia
  • 3.3.3.
  • Psychosocial Etiology of Anorexia
  • 3.4.
  • 2.
  • Current Therapies for Cancer Anorexia
  • 3.4.1.
  • Timing of Diagnosis and Intervention
  • 3.4.2.
  • Nutrition Supplementation
  • 3.4.3.
  • Appetite Stimulants and Other Pharmacotherapies to Treat Anorexia
  • 3.4.4.
  • Increase Lean Body Mass with Physical Activity
  • 3.5.
  • Assessment of Malnutrition and Nutritional Therapy Approaches in Cancer Patients
  • Guidelines for Treatment
  • 3.5.1.
  • Nutrition Guidelines
  • 3.5.2.
  • Pharmacotherapy
  • 3.5.3.
  • Speech Therapist
  • 3.5.4.
  • Physical Activity
  • 3.5.5.
  • 2.1.
  • Follow-up
  • 3.6.
  • Future Directions
  • References
  • 4.
  • Cancer Cachexia (CC)
  • 4.1.
  • Definition
  • 4.2.
  • Prevalence
  • Definition
  • 4.3.
  • Etiology of Cancer Cachexia
  • 4.3.1.
  • Potential Molecular Mechanisms of CC
  • 4.4.
  • Current Therapies for CC
  • 4.4.1.
  • Nutritional Approaches
  • 4.4.2.
  • Appetite Stimulants
Dimensions
24 cm.
Extent
xvii, 301 p.
Isbn
9783642272332
Isbn Type
(e-ISBN)
Lccn
2012931866
Other physical details
ill.
System control number
  • (CaMWU)u2864221-01umb_inst
  • 2699516
  • (Sirsi) i9783642272325
  • (OCoLC)764381698
Label
Nutritional management of cancer treatment effects, Nagi B. Kumar
Publication
Bibliography note
Includes bibliographical references and index
Contents
  • 2.2.
  • 4.4.3.
  • Physical Activity
  • 4.5.
  • Guidelines for Treatment
  • 4.5.1.
  • Nutrition Guidelines
  • 4.5.2.
  • Pharmacotherapy
  • 4.5.3.
  • Physical Activity
  • Prevalence of Malnutrition in Cancer Patients
  • 4.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 4.5.5.
  • Follow-up
  • 4.6.
  • Future Directions
  • References
  • 5.
  • Oral Mucositis
  • 5.1.
  • 2.3.
  • Definition
  • 5.2.
  • Prevalence
  • 5.3.
  • Etiology
  • 5.3.1.
  • Patient- and Treatment-Related Etiology of Mucositis
  • 5.3.2.
  • Biologic Development of Mucositis
  • 5.4.
  • Etiology of Malnutrition
  • Current Therapies for Mucositis
  • 5.4.1.
  • Assessment and Early Identification of Oral Mucositis
  • 5.4.2.
  • Treatment Approaches with Immunomodulators, Amino Acids, and Vitamins
  • 5.4.3.
  • Physical Approaches for the Prevention and Treatment of Oral Mucositis
  • 5.4.4.
  • Treatment Approaches of Related Symptom Clusters to Oral Mucositis
  • 5.5.
  • 2.3.1.
  • Guidelines for Assessment and Treatment of Oral Mucositis
  • 5.5.1.
  • Assessment of Mucositis
  • 5.5.2.
  • Dental Care Guidelines
  • 5.5.3.
  • Pharmacotherapy
  • 5.5.4.
  • Nutrition Guidelines
  • 5.5.5.
  • Tumor-Related Etiology
  • Physical Activity
  • 5.5.6.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 5.5.7.
  • Follow-up
  • 5.6.
  • Future Directions
  • References
  • 6.
  • Nausea and Vomiting in Cancer
  • 2.3.2.
  • 6.1.
  • Definition/Description
  • 6.2.
  • Prevalence
  • 6.3.
  • Etiology/Common Causes
  • 6.3.1.
  • Neurophysiology of Nausea and Vomiting
  • 6.3.2.
  • Cytotoxic Chemotherapy and Radiation-Induced Mechanisms
  • Treatment-Related Etiology
  • 6.3.3.
  • Tumor-Induced Nausea and Vomiting
  • 6.3.4.
  • Drugs Contributing to Nausea and Vomiting
  • 6.3.5.
  • Psychological Etiology
  • 6.4.
  • Current Treatment of Nausea and Vomiting
  • 6.4.1.
  • Pharmacological Approaches
  • 2.4.
  • 6.4.2.
  • Nonpharmacological Approaches
  • 6.5.
  • Guidelines for the Management of Nausea and Vomiting
  • 6.5.1.
  • Assessment
  • 6.5.2.
  • Pharmacologic Interventions
  • 6.5.3.
  • Nutrition Guidelines
  • Assessment of Malnutrition in Cancer Patients
  • 6.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 6.5.5.
  • Dentist
  • 6.5.6.
  • Follow-up
  • 6.6.
  • Future Directions
  • References
  • 7.
  • Machine generated contents note:
  • 2.4.1.
  • Cancer-Related Fatigue (CRF)
  • 7.1.
  • Definition
  • 7.2.
  • Prevalence
  • 7.3.
  • Etiology of Fatigue in Cancer
  • 7.3.1.
  • Physiological Factors
  • 7.3.2.
  • Nutritional Screening
  • Medications
  • 7.3.3.
  • Psychological Factors
  • 7.3.4.
  • Environmental Factors
  • 7.4.
  • Current Treatment Approaches
  • 7.4.1.
  • Assessment of Etiology of Fatigue
  • 7.4.2.
  • 2.4.2.
  • Pharmacological Approaches/Treating Comorbidities
  • 7.4.3.
  • Nonpharmacological Approaches
  • 7.5.
  • Guidelines
  • 7.5.1.
  • Comprehensive Assessment
  • 7.5.2.
  • Pharmacological Interventions
  • 7.5.3.
  • Nutritional Assessment
  • Nonpharmacological Interventions
  • 7.6.
  • Future Directions
  • References
  • 8.
  • Treatment-Induced Enteritis (Radiation- or Combination Therapy-Induced Enteropathies)
  • 8.1.
  • Definition
  • 8.2.
  • Prevalence
  • 2.5.
  • 8.3.
  • Etiology
  • 8.4.
  • Current Therapies for Treatment of Alimentary Tract Enteritis
  • 8.4.1.
  • Screening and Comprehensive Evaluation
  • 8.4.2.
  • Radiation Techniques
  • 8.4.3.
  • Surgical Management
  • Nutrition Therapy
  • 8.4.4.
  • Pharmaceutical Management
  • 8.4.5.
  • Nutritional Management
  • 8.5.
  • Guidelines for Treatment of Gastrointestinal Mucositis/Radiation Enteritis
  • 8.5.1.
  • Assessment and Medical/Surgical Management
  • 8.5.2.
  • Nutritional Assessment and Therapy
  • 2.5.1.
  • 8.5.3.
  • Pharmacotherapy
  • 8.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 8.5.5.
  • Follow-up
  • 8.6.
  • Future Directions
  • References
  • 9.
  • Estimation of Nutritional Needs
  • Neurocognitive Impairment (NI)
  • 9.1.
  • Definition
  • 9.2.
  • Prevalence
  • 9.3.
  • Etiology
  • 9.3.1.
  • Etiology of NI in All Cancers
  • 9.3.2.
  • 2.6.
  • Etiology of NI in Adult Cancers
  • 9.3.3.
  • Etiology of NI in Childhood Cancers and Adult Survivors of Childhood Cancers
  • 9.4.
  • Current Interventions for the Treatments for Chemotherapy-Induced Cognitive Impairment
  • 9.4.1.
  • Treatment of Anemia
  • 9.4.2.
  • Treatment of Fatigue
  • 9.4.3.
  • Route of Nutrition Intervention
  • Cognitive Training (CT)
  • 9.4.4.
  • Timing of Intervention
  • 9.5.
  • Guidelines
  • 9.5.1.
  • Neuropsycho-Oncology Referral
  • 9.5.2.
  • Nutrition Screening, Assessment, and Therapy
  • 9.5.3.
  • 1.
  • 2.6.1.
  • Physical Activity
  • 9.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 9.5.5.
  • Follow-up
  • 9.6.
  • Future Directions
  • References
  • 10.
  • Dysfunction of the Bowel/Constipation
  • Oral Intake
  • 10.1.
  • Definition
  • 10.2.
  • Prevalence
  • 10.3.
  • Etiology
  • 10.3.1.
  • Medications for Cancer Treatment
  • 10.3.2.
  • Tumor or Tumor-Radiation-Induced Constipation
  • 2.6.2.
  • 10.3.3.
  • Psychological Factors
  • 10.4.
  • Current Treatment for Cancer or Treatment-Induced Constipation
  • 10.4.1.
  • Assessment
  • 10.4.2.
  • Pharmacological Interventions
  • 10.4.3.
  • Nonpharmacological Approaches
  • Enteral Nutrition
  • 10.5.
  • Guidelines
  • 10.5.1.
  • Comprehensive Assessment
  • 10.5.2.
  • Pharmacotherapy
  • 10.5.3.
  • Nonpharmacological Interventions
  • 10.5.4.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 2.6.3.
  • 10.5.5.
  • Follow-up
  • 10.6.
  • Future Directions
  • References
  • 11.
  • Dysphagia
  • 11.1.
  • Definition/Description
  • 11.2.
  • Parenteral Nutrition
  • Prevalence
  • 11.3.
  • Etiology
  • 11.3.1.
  • Tumor Location-Related Effects
  • 11.3.2.
  • Chemotherapy-Related Effects
  • 11.3.3.
  • Radiation and Chemoradiation Therapy-Related Effects
  • 11.4.
  • 2.7.
  • Current Treatment Strategies for Dysphagia
  • 11.4.1.
  • Screening and Initial Assessment
  • 11.4.2.
  • Nutritional Interventions
  • 11.4.3.
  • Physical Therapy
  • 11.4.4.
  • Pharmacotherapies
  • 11.5.
  • Reassessment and Follow-up Nutritional Care
  • Guidelines
  • 11.5.1.
  • Nutrition Guidelines
  • 11.5.2.
  • Speech Pathologist/Radiologist
  • 11.5.3.
  • Nutrition Intervention
  • 11.5.4.
  • Dentist
  • 11.5.5.
  • 2.8.
  • Pharmacotherapy
  • 11.5.6.
  • Physical Activity
  • 11.5.7.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 11.5.8.
  • Follow-up
  • 11.6.
  • Future Directions
  • References
  • Patient and Family Communication/Education
  • 12.
  • Alterations in Taste and Smell
  • 12.1.
  • Definition
  • 12.2.
  • Prevalence
  • 12.3.
  • Etiology/Common Causes
  • 12.3.1.
  • Chemotherapy Induced
  • Introduction
  • 2.9.
  • 12.3.2.
  • Radiation Therapy Induced
  • 12.3.3.
  • Other Causes of Taste and Smell Alterations in Cancer
  • 12.4.
  • Current Treatment Strategies
  • 12.4.1.
  • Assessment
  • 12.4.2.
  • Pharmacological
  • Communication with Interdisciplinary Team
  • 12.4.3.
  • Nonpharmacological
  • 12.5.
  • Guidelines for Management
  • 12.5.1.
  • Education of Patient and Family About These Symptoms
  • 12.5.2.
  • Referral to Dentist
  • 12.5.3.
  • Treatment of Infections
  • 2.10.
  • 12.5.4.
  • Screening for Alterations in Taste and Smell
  • 12.5.5.
  • Current Treatment
  • 12.5.6.
  • Other Causes Must Be Examined
  • 12.5.7.
  • Nutrition Guidelines
  • 12.5.8.
  • Pharmacotherapy
  • Future Directions
  • 12.5.9.
  • Markers and Instruments for Patient Monitoring and Assessment of Response to Treatment by the Interdisciplinary Medical Team
  • 12.5.10.
  • Follow-up
  • 12.6.
  • Future Directions
  • References
  • References
  • 3.
  • Cancer Anorexia (CA)
  • 3.1.
  • Definition/Description
  • 3.2.
  • References
  • Prevalence
  • 3.3.
  • Etiology and Potential Mechanisms
  • 3.3.1.
  • Tumor- and Treatment-Related Etiology of Anorexia
  • 3.3.2.
  • Perturbations of the Physiological Regulation of Eating Behavior as Etiology of Anorexia
  • 3.3.3.
  • Psychosocial Etiology of Anorexia
  • 3.4.
  • 2.
  • Current Therapies for Cancer Anorexia
  • 3.4.1.
  • Timing of Diagnosis and Intervention
  • 3.4.2.
  • Nutrition Supplementation
  • 3.4.3.
  • Appetite Stimulants and Other Pharmacotherapies to Treat Anorexia
  • 3.4.4.
  • Increase Lean Body Mass with Physical Activity
  • 3.5.
  • Assessment of Malnutrition and Nutritional Therapy Approaches in Cancer Patients
  • Guidelines for Treatment
  • 3.5.1.
  • Nutrition Guidelines
  • 3.5.2.
  • Pharmacotherapy
  • 3.5.3.
  • Speech Therapist
  • 3.5.4.
  • Physical Activity
  • 3.5.5.
  • 2.1.
  • Follow-up
  • 3.6.
  • Future Directions
  • References
  • 4.
  • Cancer Cachexia (CC)
  • 4.1.
  • Definition
  • 4.2.
  • Prevalence
  • Definition
  • 4.3.
  • Etiology of Cancer Cachexia
  • 4.3.1.
  • Potential Molecular Mechanisms of CC
  • 4.4.
  • Current Therapies for CC
  • 4.4.1.
  • Nutritional Approaches
  • 4.4.2.
  • Appetite Stimulants
Dimensions
24 cm.
Extent
xvii, 301 p.
Isbn
9783642272332
Isbn Type
(e-ISBN)
Lccn
2012931866
Other physical details
ill.
System control number
  • (CaMWU)u2864221-01umb_inst
  • 2699516
  • (Sirsi) i9783642272325
  • (OCoLC)764381698

Library Locations

  • Albert D. Cohen Management LibraryBorrow it
    181 Freedman Crescent, Winnipeg, MB, R3T 5V4, CA
    49.807878 -97.129961
  • Architecture/Fine Arts LibraryBorrow it
    84 Curry Place, Winnipeg, MB, CA
    49.807716 -97.136226
  • Archives and Special CollectionsBorrow it
    25 Chancellors Circle (Elizabeth Dafoe Library), Room 330, Winnipeg, MB, R3T 2N2, CA
    49.809961 -97.131878
  • Bibliothèque Alfred-Monnin (Université de Saint-Boniface)Borrow it
    200, avenue de la Cathédrale, Local 2110, Winnipeg, MB, R2H 0H7, CA
    49.888861 -97.119735
  • Bill Larson Library (Grace Hospital)Borrow it
    300 Booth Drive, G-227, Winnipeg, MB, R3J 3M7, CA
    49.882400 -97.276436
  • Carolyn Sifton - Helene Fuld Library (St. Boniface General Hospital)Borrow it
    409 Tache Avenue, Winnipeg, MB, R2H 2A6, CA
    49.883388 -97.126050
  • Concordia Hospital LibraryBorrow it
    1095 Concordia Avenue, Winnipeg, MB, R2K 3S8, CA
    49.913252 -97.064683
  • Donald W. Craik Engineering LibraryBorrow it
    75B Chancellors Circle (Engineering Building E3), Room 361, Winnipeg, MB, R3T 2N2, CA
    49.809053 -97.133292
  • E.K. Williams Law LibraryBorrow it
    224 Dysart Road, Winnipeg, MB, R3T 5V4, CA
    49.811829 -97.131017
  • Eckhardt-Gramatté Music LibraryBorrow it
    136 Dafoe Road (Taché Arts Complex), Room 257, Winnipeg, MB, R3T 2N2, CA
    49.807964 -97.132222
  • Elizabeth Dafoe LibraryBorrow it
    25 Chancellors Circle, Winnipeg, MB, R3T 2N2, CA
    49.809961 -97.131878
  • Fr. H. Drake Library (St. Paul's College)Borrow it
    70 Dysart Road, Winnipeg, MB, R3T 2M6, CA
    49.810605 -97.138184
  • J.W. Crane Memorial Library (Deer Lodge Centre)Borrow it
    2109 Portage Avenue, Winnipeg, MB, R3J 0L3, CA
    49.878000 -97.235520
  • Libraries Annex (not open to the public; please see web page for details)Borrow it
    25 Chancellors Circle (in the Elizabeth Dafoe Library), Winnipeg, MB, R3T 2N2, CA
    49.809961 -97.131878
  • Neil John Maclean Health Sciences LibraryBorrow it
    727 McDermot Avenue (Brodie Centre), 200 Level, Winnipeg, MB, R3E 3P5, CA
    49.903563 -97.160554
  • Sciences and Technology LibraryBorrow it
    186 Dysart Road, Winnipeg, MB, R3T 2M8, CA
    49.811526 -97.133257
  • Seven Oaks General Hospital LibraryBorrow it
    2300 McPhillips Street, Winnipeg, MB, R2V 3M3, CA
    49.955177 -97.148865
  • Sister St. Odilon Library (Misericordia Health Centre)Borrow it
    99 Cornish Avenue, Winnipeg, MB, R3C 1A2, CA
    49.879592 -97.160425
  • St. John's College LibraryBorrow it
    92 Dysart Road, Winnipeg, MB, R3T 2M5, CA
    49.811242 -97.137156
  • Victoria General Hospital LibraryBorrow it
    2340 Pembina Highway, Winnipeg, MB, R3T 2E8, CA
    49.806755 -97.152739
  • William R Newman Library (Agriculture)Borrow it
    66 Dafoe Road, Winnipeg, MB, R3T 2R3, CA
    49.806936 -97.135525
Processing Feedback ...